Skip to content

A study on risk of developing heart disease in patients with skin disease called psoriasis marked by red, itchy, scaly patches.

A study on cardiovascular risk factors in patients with psoriasis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/08/003928
Enrollment
60
Registered
2013-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Newly diagnosed adults ( men and women) with psoriasis and adults without Psoriasis attending outpatient department of Father Muller Medical College Dermatology Department

Interventions

Control Intervention1: Fasting lipid profile estimation: Estimate fasting lipid profile levels in patients with psoriasis to identify cardiac risk

Sponsors

Father Muller Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All newly diagnosed cases of psoriasis above the age of 18 years. 2. Patients willing to participate in the study and undergo necessary investigations.

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years. 2. Specific treatment [like Methotrexate, Biologics] taken for psoriasis in last one month prior to enrollment in the study. 3. Patients on medications affecting carbohydrate and lipid metabolism [Beta blockers, Thiazides, Corticosteroids and lipid lowering agents]. 4. Pregnant and lactating women. 5. Patients not willing for the study.

Design outcomes

Primary

MeasureTime frame
Association of Psoriasis and cardiovascular risk factorsTimepoint: At the time of recruitment

Secondary

MeasureTime frame
Association of cardiovascular risk and severity of PsoriasisTimepoint: At the time of recruitment

Countries

India

Contacts

Public ContactDr Asha R V

Father Muller Medical Clooege

sukumar@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026